ALMR
NASDAQAlamar Biosciences Inc.
News16/Ratings0
News · 26 weeks16+100%
2025-10-262026-04-19
Mix1690d
- Insider9(56%)
- Other4(25%)
- SEC Filings3(19%)
Latest news
16 items- SECSEC Form SCHEDULE 13D filed by Alamar Biosciences Inc.SCHEDULE 13D - Alamar Biosciences, Inc. (0002104204) (Subject)
- SECSEC Form SCHEDULE 13D filed by Alamar Biosciences Inc.SCHEDULE 13D - Alamar Biosciences, Inc. (0002104204) (Subject)
- INSIDERSEC Form 4 filed by Qiming Corporate Gp Vi, Ltd.4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- SECSEC Form EFFECT filed by Alamar Biosciences Inc.EFFECT - Alamar Biosciences, Inc. (0002104204) (Filer)
- INSIDERSEC Form 4 filed by Illumina Innovation Fund Ii Gp, L.L.C.4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- INSIDERSEC Form 4 filed by Chambers Rebecca4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- INSIDERSEC Form 4 filed by Witney Frank4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- INSIDERSEC Form 4 filed by White Timothy Ogden4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- INSIDERSEC Form 4 filed by Chen Shiping4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- INSIDERSEC Form 4 filed by Luo Yuling4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- INSIDERSEC Form 4 filed by Mcanear Justin J.4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- INSIDERSEC Form 4 filed by Naclerio Nicholas4 - Alamar Biosciences, Inc. (0002104204) (Issuer)
- SECSEC Form S-8 filed by Alamar Biosciences Inc.S-8 - Alamar Biosciences, Inc. (0002104204) (Filer)
- SECSEC Form 8-K filed by Alamar Biosciences Inc.8-K - Alamar Biosciences, Inc. (0002104204) (Filer)
- SECSEC Form POS AM filed by Alamar Biosciences Inc.POS AM - Alamar Biosciences, Inc. (0002104204) (Filer)
- PRPrecision Proteomics Leader Alamar Biosciences Lists on NASDAQSHANGHAI, April 20, 2026 /PRNewswire/ -- Alamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ Stock Exchange on April 17th, 2026, Beijing Time. Alamar (NASDAQ:ALMR) issued shares at a price of $17 per share and opened at $22.6 per share with a market capitalization of approximately $1.5 billion. Qiming Venture Partners led Alamar's Series A financing in 2020 and continued to fund the company's development in the following Series B and Series C rounds. Before the company's IPO, Qiming Venture Partners held approximately 19.2% stake in Alamar and was one of its most important institutional investors.Fo